If you have been reading about amino acid sequence and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-02-08. Numbers and descriptions here follow the published literature rather than marketing material.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
=== Dextran prodrug applications === These drug-polymer complexes have advantages such as longer drug half-life and improved targeted drug delivery. Dextran prodrugs have potential applications in the treatment of liver diseases, pulmonary diseases, colonic diseases, and cancer.
== Bibliography == K.F. Warner, "Boning Lamb Cuts", Leaflet 74, U.S. Department of Agriculture, Bureau of Animal Industry, June 1931. full text. Bob Kennard, "Much ado about mutton". Ludlow: Merlin Unwin, 2014.
=== Blood for Britain === The Blood for Britain program during the early 1940s was quite successful (and popular in the United States) based on Charles Drew's contribution. A large project began in August 1940 to collect blood in New York City hospitals for the export of plasma to Britain. Drew was appointed medical supervisor of the "Plasma for Britain" project. His notable contribution at this time was to transform the test tube methods of many blood researchers into the first successful mass production techniques. Nevertheless, the decision was made to develop a dried plasma package for the armed forces as it would reduce breakage and make the transportation, packaging, and storage much simpler. The resulting dried plasma package came in two tin cans containing 400 cc bottles. One bottle contained enough distilled water to reconstitute the dried plasma contained within the other bottle. In about three minutes, the plasma would be ready to use and could stay fresh for around four hours. The Blood for Britain program operated successfully for five months, with total collections of almost 15,000 people donating blood, and with over 5,500 vials of blood plasma. Following the Supplying Blood Plasma to England project, Drew was named director of the Red Cross blood bank and assistant director of the National Research Council, in charge of blood collection for the United States Army and Navy. Drew argued against the armed forces directive that blood/plasma was to be separated by the race of the donor.
==== September ==== On 1 September, the National Guard attacked the Walgha, Al-Majdal and Al-Mazraa fronts with a drone, then the Internal Security Forces clashed with the National Guard, leaving 10 members of the Internal Security Forces injured, conversely, the National Guard claimed that the Internal Security Forces launched mortar rounds and fired machine guns. On 4 September, groups considered as "outlaws" forced the expulsion of Atef Hneidi, known as "al-Basha", from the Suwayda governorate, this comes after Atef Hneidi issued a statement criticizing Hikmat al-Hijri. On 6 September, clashes broke out between the National Guard and the Syrian government forces, in the villages of Rima Hazem and Al-Mansoura, involving the use of heavy machine guns. On 10 September, Syrian state television reported that "criminal groups" blocked the al-Matouna checkpoint, meanwhile, a source in Suwayda claimed that Syrian internal security forces stationed in al-Matouna blocked the passage of tourists to Damascus without any explanation. On 24 September, Syrian government forces opened fire with machine guns on the city of Suwayda, and the National Guard responded to the attacks.
=== Belgium === In Belgium, a clinical biologist (biologiste clinique) is a medical doctor or pharmacist who has completed a five-year postgraduate specialization in clinical biology (biologie clinique). This specialization is regulated by the Belgian Ministry of Public Health, and clinical biologists work in both hospital and private laboratories. Their training includes rotations in different laboratory disciplines, including hematology, microbiology, and clinical chemistry. They are responsible for interpreting laboratory results, ensuring quality control, and advising clinicians on diagnostic strategies.
Sources: en.wikipedia.org
=== Deconvolution of tethered combinatorial libraries === If the peptides are not cleaved from the solid support, it can lead to a mixture of beads, each bead containing a single peptide. Smith and his colleagues showed earlier that peptides could be tested in tethered form, too. This approach was also used in screening peptide libraries. The tethered peptide library was tested with a dissolved target protein. The beads to which the protein was attached were picked out, removed the protein from the bead then the tethered peptide was identified by sequencing. A somewhat different approach was followed by Taylor and Morken. They used infrared thermography to identify catalysts in non-peptide tethered libraries. The method is based on the heat that is evolved in the beads that contain a catalyst when the tethered library immersed into a solution of a substrate. When the beads are examined through an infrared microscope, the catalyst containing beads appear as bright spots and can be picked out.
=== Europe === Following discussions on the safety of certain pharmaceutical products derived from kava and sold in Germany, the EU imposed a temporary ban on imports of kava-based pharmaceutical products in 2002. The sale of kava plant became regulated in Switzerland, France, and in prepared form in the Netherlands. Some Pacific island states, which had been benefiting from the export of kava to the pharmaceutical companies, have attempted to overturn the EU ban on kava-based pharmaceutical products by invoking international trade agreements: Fiji, Samoa, Tonga, and Vanuatu argued at the WTO that the ban was imposed with insufficient evidence. The pressure prompted Germany to reconsider the evidence base for banning kava-based pharmaceutical products. On 10 June 2014, the German Administrative Court overturned the 2002 ban, making selling kava as a medicine legal, albeit strictly regulated; personal possession of kava has never been illegal. In Germany, kava-based pharmaceutical preparations are currently prescription drugs. Furthermore, patient and professional information brochures have been redesigned to warn about potential side effects. These strict measures have been opposed by some of the leading kava scientists. In early 2016, a court case was filed against the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM/German Federal Institute for Drugs and Medical Devices), arguing that the new regulatory regime is too strict and not justified.
== January 22, 1982 (Friday) == In the U.S. state of Washington, the board of directors of the state's Public Power Supply System voted to halt further construction of two nuclear power plants, bringing the number of construction permit revocations to 30 in the U.S. since the beginning of 1979. The first convictions in the U.S., on criminal charges of slavery resulting in death, were issued by a federal jury in North Carolina for Dennis Warren, a migrant labor crew leader, and along with his brother Richard Warren, and his assistant John Lester Harris. Died: Eduardo Frei, 71, President of Chile from 1964 to 1970 and a critic of the regime of President Augusto Pinochet, died after having surgery at a hospital in Santiago for a hiatal hernia, reported initially as death from sepsis. More than 35 years later, allegations would be made that Frei had been poisoned by members of Pinochet's secret police organization, the CNI and although six defendants would be found guilty of homicide in 2019, the convictions would be overturned on appeal and a Chilean court would conclude that Frei was not a victim of homicide. Hans Fidesser, 90, Austrian opera tenor Ragini Devi (stage name for Esther Sherman), 88, American performer of Indian classical dance Edward Farber, 67, American photographer and inventor of the portable strobe light.
In 1299, according to the Malay Annals, the Kingdom of Singapura was founded on the island by Sang Nila Utama. Although the historicity of the accounts as given in the Malay Annals is the subject of academic debates, it is nevertheless known from various documents that Singapore in the 14th century, then known as Temasek, was a trading port under the influence of both the Majapahit Empire and the Siamese kingdoms, and was a part of the Indosphere. These Indianised kingdoms were characterised by surprising resilience, political integrity and administrative stability. Historical sources also indicate that around the end of the 14th century, its ruler Parameswara was attacked by either the Majapahit or the Siamese, forcing him to move to Malacca where he founded the Sultanate of Malacca. Archaeological evidence suggests that the main settlement on Fort Canning Hill was abandoned around this time, although a small trading settlement continued in Singapore for some time afterwards. In 1613, Portuguese raiders burned down the settlement, and the island faded into obscurity for the next two centuries. By then, Singapore was nominally part of the Johor Sultanate. The wider maritime region and much trade was under Dutch control for the following period after the 1641 Dutch conquest of Malacca.
Lung disease: Lung cancer Interstitial lung disease most commonly idiopathic pulmonary fibrosis Complicated tuberculosis Suppurative lung disease: lung abscess, empyema, bronchiectasis, cystic fibrosis Mesothelioma of the pleura Sarcoidosis Heart disease: Any disease featuring chronic hypoxia Cyanotic heart defect (most common cardiac cause) Infective endocarditis Atrial myxoma (benign tumor) Arteriovenous fistula or malformation Gastrointestinal and hepatobiliary: Malabsorption Crohn's disease and ulcerative colitis Cirrhosis, especially in primary biliary cholangitis Hepatopulmonary syndrome, a complication of cirrhosis Others: Graves' disease (autoimmune hyperthyroidism) – in this case, it is known as thyroid acropachy Familial and hereditary clubbing and "pseudoclubbing" (people of African descent often have what appears to be clubbing) Vascular anomalies of the affected arm such as an axillary artery aneurysm (in unilateral clubbing) Primary hypertrophic osteoarthropathy Nail clubbing is not specific to chronic obstructive pulmonary disease (COPD). Therefore, in patients with COPD and significant degrees of clubbing, a search for signs of bronchogenic carcinoma (or other causes of clubbing) might still be indicated.
Sources: en.wikipedia.org
First, during exercise, carbohydrates with the highest possible rate of conversion to blood glucose (high glycemic index) are ingested continuously. The best possible outcome of this strategy replaces about 35% of glucose consumed at heart rates above about 80% of maximum. Second, through endurance training adaptations and specialized regimens (e.g. fasting, low-intensity endurance training), the body can condition type I muscle fibers to improve both fuel use efficiency and workload capacity to increase the percentage of fatty acids used as fuel, sparing carbohydrate use from all sources. Third, by consuming large quantities of carbohydrates after depleting glycogen stores as a result of exercise or diet, the body can increase storage capacity of intramuscular glycogen stores. This process is known as carbohydrate loading. In general, glycemic index of carbohydrate source does not matter since muscular insulin sensitivity is increased as a result of temporary glycogen depletion. When athletes ingest both carbohydrate and caffeine following exhaustive exercise, their glycogen stores tend to be replenished more rapidly; however, the minimum dose of caffeine at which there is a clinically significant effect on glycogen repletion has not been established.
=== Adherence === It has been repeatedly found that in the long-term, all diets with the same calorific value perform the same for weight loss, except for the one differentiating factor of how well people can faithfully follow the dietary programme. A study comparing groups taking low-fat, low-carbohydrate and Mediterranean diets found at six months the low-carbohydrate diet still had most people adhering to it, but thereafter the situation reversed: at two years the low-carbohydrate group had the highest incidence of lapses and dropouts. This may be due to the comparatively limited food choice of low-carbohydrate diets.
Additional records indicate that distinct morphological forms occur in anthropogenic habitats. A granulose form (formerly known as Xanthoria aureola) has been recorded predominantly on roofs in southeastern England.
received more than 40 mg prednisone (or equivalent) daily for more than one week been given repeat doses in the evening received more than three weeks of treatment recently received repeated courses (particularly if taken for longer than three weeks) taken a short course within one year of stopping long-term therapy other possible causes of adrenal suppression Systemic corticosteroids may be stopped abruptly in those whose disease is unlikely to relapse who have received treatment for three weeks or less and who are not included in the patient groups described above. During corticosteroid withdrawal, the dose may be reduced rapidly down to physiological doses (equivalent to prednisolone 7.5 mg daily) and then reduced more slowly. Assessment of the disease may be needed during withdrawal to ensure that relapse does not occur.
Moluccans are the Melanesian-Austronesian ethnic groups indigenous to the Maluku Islands (also called the Moluccas). The region was historically known as the Spice Islands, and today consists of two Indonesian provinces of Maluku and North Maluku. As such, the term Moluccans is used as a blanket term for the various ethnic and linguistic groups native to the islands. Most Moluccans practice Islam, followed by Christianity. Despite religious differences, all groups share strong cultural bonds and a sense of common identity, such as through Adat. Music is also a binding factor, playing an important role in the cultural identity, and the Moluccan capital city of Ambon was awarded the official status of City of Music by UNESCO in 2019. As of 2018, a Moluccan diaspora community of c. 70,000 people lives in the Netherlands. This group consists mainly of descendants of soldiers from the former Royal Netherlands East Indies Army, who were evacuated to the Netherlands after the Indonesian invasion of South Maluku in 1950. The remainder are descended from Moluccan servicemen in the Royal Netherlands Navy and civil servants who left Dutch New Guinea after the New York Agreement came into effect in 1962. However, the vast majority of Moluccans living outside the Maluku Islands are found in surrounding regions, such as Western New Guinea, Timor-Leste, West Timor, North Sulawesi, and further west.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.